Tesaro: What’s Tearing At The Stock?
June 05, 2017 at 12:48 PM EDT
The drug maker Tesaro isn't getting much of a boost from ASCO. The stock is falling today despite some pretty bullish research notes about the launch of its new ovarian cancer treatment.